Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-7 of 7 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2017Leptin signals via TGFB1 to promote metastatic potential and stemness in breast cancerMishra, A.; Parish, C.; Wong, M.; Licinio, J.; Blackburn, A.; Ahmad, A.
2021The BMP antagonist Gremlin1 contributes to the development of cortical excitatory neurons, motor balance and fear responsesSuzuki, M.; Suzuki, N.; Wang, T.; Kobayashi, H.; Vrbanac, L.; Ng, J.Q.; Wright, J.A.; Lannagan, T.R.M.; Gieniec, K.A.; Lewis, M.; Ando, R.; Enomoto, A.; Koblar, S.; Thomas, P.; Worthley, D.L.; Woods, S.L.
2014Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinomaAl-Ejeh, F.; Pajic, M.; Shi, W.; Kalimutho, M.; Miranda, M.; Nagrial, A.; Chou, A.; Biankin, A.; Grimmond, S.; Brown, M.; Khanna, K.
2004A crucial role of caspase-3 in osteogenic differentiation of bone marrow stromal stem cellsMiura, M.; Chen, X.; Allen, M.; Bi, Y.; Gronthos, S.; Seo, B.; Lakhani, S.; Flavell, R.; Feng, X.; Robey, P.; Young, M.; Shi, S.
2010Immunomodulatory properties of stem cells from human exfoliated deciduous teethYamaza, T.; Kentaro, A.; Chen, C.; Liu, Y.; Shi, Y.; Gronthos, S.; Wang, S.; Shi, S.
2012Dual targeting of the epidermal growth factor receptor using the combination of cetuximab and erlotinib: Preclinical evaluation and results of the Phase II DUX Study in chemotherapy-refractory, advanced colorectal cancerWeickhardt, A.; Price, T.; Chong, G.; Gebski, V.; Pavlakis, N.; Johns, T.; Azad, A.; Skrinos, E.; Fluck, K.; Dobrovic, A.; Salemi, R.; Scott, A.; Mariadason, J.; Tebbutt, N.
2012In Vitro assays using primary embryonic mouse lymphatic endothelial cells uncover key roles for FGFR1 signalling in lymphangiogenesisKazenwadel, J.; Secker, G.; Betterman, K.; Harvey, N.; Kume, T.